摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Cu(I)(pyrazine)Cl]n | 171862-25-2

中文名称
——
中文别名
——
英文名称
[Cu(I)(pyrazine)Cl]n
英文别名
CuCl(pyrazine);[CuCl(pyz)];CuCl(pyz);chlorocopper;pyrazine
[Cu(I)(pyrazine)Cl]n化学式
CAS
171862-25-2
化学式
C4H4N2*Cl*Cu
mdl
——
分子量
179.088
InChiKey
CFYMZLONFNYTJI-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.52
  • 重原子数:
    8.0
  • 可旋转键数:
    0.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.78
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

反应信息

  • 作为产物:
    描述:
    吡嗪 、 copper(II) choride dihydrate 在 KOH 、 2,3-dihydroxyfumaric acid 作用下, 以 甲醇 为溶剂, 生成 [Cu(I)(pyrazine)Cl]n
    参考文献:
    名称:
    轻松合成阴离子依赖性多用途Cu I和混合价多孔Cu I / Cu II骨架†
    摘要:
    的CuX 2(X = CLO 4 -,NO 3 -,0.5 SO 4 2-,氯−)和2,3-二羟基富马酸 (dhfa)在弱碱性水溶液中发生氧化还原反应 铜我X 和 2,3-二酮丁二酸。 吡嗪 (pyz)和 1,2-双(4-吡啶基)乙烯 (bpee)接头已用于稳定和分离该反应中的Cu I态。三种不同的Cu我-frameworks,{的Cu(PYZ)1.5(CLO 4)} Ñ(1),{的Cu(PYZ)(NO 3)} Ñ(2),和{[铜(bpee)CL]·2H已经合成了具有不同阴离子的2 O} n(3)并对其进行了结构表征。骨架的拓扑和维数取决于阴离子。这是一步的综合铜我 与dhfa和1有关的化学计量比为1:2的协调框架 铜II。通过控制dhfa的浓度,混合价多孔铜我/ Cu II框架,已经合成了[Cu II Cu I 2(2,4-pyrdc)2(pyz)3 ]·2H 2 O} n(4)并通过X
    DOI:
    10.1039/b922039a
点击查看最新优质反应信息

文献信息

  • Luminescence properties of “double-stranded staircase” copper(i) halide coordination polymers with N-containing ligands
    作者:Jiri Pospisil、Inke Jess、Christian Näther、Marek Necas、Petr Taborsky
    DOI:10.1039/c0nj00809e
    日期:——
    A set of CuIXL coordination polymers (X = Cl, Br, I; L = derivatives of pyrazine and bipyridine) with double-stranded staircase structures was analyzed by X-ray crystallography and luminescence spectroscopy to find a relationship between the structure and luminescence properties of the polymers. Our measurements have proved that luminescence emission wavelengths varied between 500–750 nm, after the polymers were irradiated by light with a wavelength of 370 nm. Although each coordination polymer has shown different emission maximum, we observed several interesting trends related to the structure of the compounds. There is a clear correlation between the emission maxima and the halide size and/or Cu–X distance, respectively. On the other hand, the substitution of the ligand L (pyrazine derivatives, 4,4′-bipyridine) has no significant contribution to the emission spectra. This observation supports the theory that the halide to metal charge transfer (XMCT) plays a key role in the photoluminescence of staircase polymers.
    我们通过 X 射线晶体学和发光光谱学分析了一组具有双链阶梯结构的 CuIXL 配位聚合物(X = Cl、Br、I;L = 吡嗪和双吡啶的衍生物),以找到聚合物结构与发光特性之间的关系。测量结果表明,在波长为 370 纳米的光照射下,聚合物的发光波长在 500-750 纳米之间变化。虽然每种配位聚合物的发射最大值各不相同,但我们观察到了几种与化合物结构有关的有趣趋势。发射最大值分别与卤化物尺寸和/或 CuâX 间距有明显的相关性。另一方面,配体 L 的替换(吡嗪生物、4,4â²-联吡啶)对发射光谱没有明显影响。这一观察结果支持了卤化物到属的电荷转移(XMCT)在阶梯聚合物的光致发光中起关键作用的理论。
  • One- and Two- Dimensional Copper(I) Halide Based Coordination Polymers with Bridging Pyridazine or Pyrimidine Ligands
    作者:T. Kromp、W. S. Sheldrick
    DOI:10.1515/znb-1999-0914
    日期:1999.9.1

    1-Dimensional coordination polymers 1 [CuX(μ-pydz)] 1 - 3 (X = Cl, Br, I; pydz = pyridazine) may be prepared by self-assembly in acetonitrile solution at 120 °C (1) or room temperature (2, 3). Individual chains contain (CuX)2 rings and dimeric [Cu(μ-pydz)]2 substructures. At a 2:1 molar ratio treatment of CuI with pydz in acetonitrile affords the lamellar complex 2 [(Cul)2(μ-pydz)] (4) whose novel 2 [(Cul)2] sheets contain fused 4-, 6- and 8-membered (Cul)n rings and are stabilized by pydz bridging between adjacent Cu atoms. In contrast,2 [(CuBr)2(μ-pym)2] (5) (pym = pyrimidine) contains separated 1 [CuBr] chains and (CuBr)2 rings as participating building units.

    1维配位聚合物[ CuX(μ-pydz)] 1 - 3 (X = Cl, Br, I; pydz = pyridazine) 可以在乙腈溶液中以自组装的方式在 120°C (1) 或室温 (2, 3) 下制备。单个链包含 (CuX)2 环和二聚体 [Cu(μ-pydz)]2 亚结构。在乙腈中以2:1的摩尔比处理 CuI 和 pydz 可以得到层状复合物[(Cul)2(μ-pydz)] (4),其新颖的[(Cul)2]片含有融合的 4-, 6- 和 8-成员环,并通过 pydz 在相邻 Cu 原子之间的桥接稳定。相比之下,[(CuBr)2(μ-pym)2] (5) (pym = pyrimidine) 含有分离的[CuBr]链和(CuBr)2环作为参与构建单元。
  • Hydrothermal Syntheses, Structures, and Properties of [Cu<sub>3</sub>Cl<sub>2</sub>CN(pyrazine)] and Copper(I) Halide Pyrazine Polymers
    作者:Nicole S. Persky、Jessica M. Chow、Karalee A. Poschmann、Nanette N. Lacuesta、Sarah L. Stoll、Simon G. Bott、Steven Obrey
    DOI:10.1021/ic000185a
    日期:2001.1.1
    Crystals of copper halide and pseudohalide compounds with pyrazine are synthesized under hydrothermal conditions. The title compound, [Cu3Cl2CNPz] (1) (Pz = pyrazine), is a new copper compound exhibiting an unusual -(Cu3Cl2)- polymeric stair structural motif and three-coordinate cyanide. Compound 1 crystallizes in the monoclinic space group P2(1)/m, with a = 3.6530(7) A, b = 17.160(3) A, c = 6.9800(14)
    热条件下合成卤化和拟卤化物与吡嗪的晶体。标题化合物[Cu3Cl2CNPz](1)(Pz =吡嗪)是一种新型的化合物,表现出不同寻常的-(Cu3Cl2)-聚合物楼梯结构图案和三配位化物。化合物1在单斜空间群P2(1)/ m中结晶,其中a = 3.6530(7)A,b = 17.160(3)A,c = 6.9800(14)A,β= 90.58(3)度和Z =2。另外,X = Cl(2),Br(3)和I(4)的配合物系列[Cu2X2Pz]在热条件下也会结晶。无机聚合物[Cu2Br2Pz](3)属于三斜空间群P1,a = 6.9671(14)A,b = 7.849(2)A,c = 8.099(2)A,α= 71.69(3)度, beta = 70.71(3)度,gamma = 85.43(3)度,Z =2。结构3,与[Cu2Cl2Pz](2)的最近报道的结构相似(Kawata,S .;
  • Two- and Three-Dimensional Mixed-Valence Cu(I)–Cu(II) Coordination Polymers: Syntheses and Characterization of α-, β-[Cu2X(C5H3N2O2)2(H2O)] (X=Cl, Br)
    作者:Li-Min Zheng、Xiqu Wang、Allan J. Jacobson
    DOI:10.1006/jssc.2000.8680
    日期:2000.6
    formula α-[Cu2X(C5H3N2O2)2(H2O)]n [X=Cl(1), Br(3), C5H3N2O2=2-pyrazinecarboxylate] and their isomers β-[Cu2X(C5H3N2O2)2 (H2O)]n [X=Cl(2), Br(4)] have been synthesized and structurally characterized. Crystal data: 1, orthorhombic, Pbca, a=12.8040(7), b=7.7323(4), c=26.104(1) Å, V=2584.4(2) Å3, Z=8, R1=0.0559; 2, triclinic, P, a=6.1908(7), b=7.7246(8), c=13.968(2) Å, α=78.853(2), β=81.455(2), γ=78.036(2)°
    具有式α- [Cu 2 X(C 5 H 3 N 2 O 2)2(H 2 O)] n [ X = Cl(1),Br(3),C 5 H 3 N 2的新型混合价化合物O 2 = 2-吡嗪羧酸酯]及其异构体β- [Cu 2 X(C 5 H 3 N 2 O 2)2(H 2 O)] n [ X= Cl(2),Br(4)]已经合成并在结构上表征。晶体数据:1,斜方晶系,PBCA,一个= 12.8040(7),b = 7.7323(4),C ^ = 26.104(1)埃,V = 2584.4(2)埃3,Ž = 8,- [R 1 = 0.0559; 2,三斜线,P,a = 6.1908(7),b = 7.7246(8),c = 13.968(2)Å,α = 78.853(2),β = 81.455(2),γ = 78.036(2)°,V = 637.0(1)埃3,ž = 2,- [R 1 = 0.0592;
  • P <sub>4</sub> S <sub>3</sub> and P,P′ or N,N′ Donors as Competitive Building Blocks in Copper(I) Coordination Polymers
    作者:Andreas Biegerl、Dmitry Piryazev、Manfred Scheer、Joachim Wachter、Alexander Virovets、Manfred Zabel
    DOI:10.1002/ejic.201100444
    日期:2011.9
    simple model system the reaction of a mixture of P4S3, PEt3, and CuX (X = Cl, Br, I) was studied. According to X-ray diffraction analysis, pseudotetrahedral monomers [CuX(PEt3)2(P4S3)] (1–3) were formed, in which P4S3 coordinates through the apical phosphorus atom. Layering a mixture of P4S3, Ph2PCH2CH2PPh2 (dppe), and toluene with CuCl in MeCN under diffusion conditions gives 1D-[CuCl(dppe)(MeCN)] (6),
    描述了结合有机 P,P' (dppe) 或 N,N' (吡嗪) 配体和无机供体 (P4S3) 作为 (I) 卤化物聚集体之间的交联剂的杂化聚合物的合成和表征。作为一个简单的模型系统,研究了 、PEt3 和 CuX(X = Cl、Br、I)的混合物的反应。根据 X 射线衍射分析,形成了假四面体单体 [CuX(PEt3)2( )] (1-3),其中 通过顶端原子配位。在扩散条件下,将 、Ph2PCH2CH2PPh2 (dppe) 和甲苯与 CuCl 的混合物在 MeCN 中分层得到 1D-[CuCl(dppe)(MeCN)] (6),其中包含 (Cu2Cl2)2(μ-dppe)2 簇连接通过另一个 dppe 配体。与 CuI 的类似反应得到 1D-[CuI( )(dppe)] (7),它由交替的反式-(Cu2I2)( )2 单元和 dppe 接头组成。如果使用
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)